PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study

Background: Health status outcomes, including symptoms, functional status, and quality of life, are critically important outcomes from patients’ perspectives. The PORTRAIT study (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) was designed to prospectively define health status outcomes and examine associations between patients’ characteristics and care to these outcomes among those presenting with new-onset or worsened claudication. Methods and Results: PORTRAIT screened 3637 patients with an abnormal ankle-brachial index and new, or worsened, claudication symptoms from 16 peripheral arterial disease (PAD) specialty clinics in the United States, the Netherlands, and Australia between June 2, 2011, and December 3, 2015. Of the 1608 eligible patients, 1275 (79%) were enrolled. Before treatment, patients were interviewed to obtain their demographics, PAD symptoms and health status, psychosocial characteristics, preferences for shared decision-making, socioeconomic, and cardiovascular risk factors. Patients’ medical history, comorbidities, and PAD diagnostic information were abstracted from patients’ medical records. Serial information about patients’ health status, psychosocial, and lifestyle factors was collected at 3, 6, and 12 months by a core laboratory. Follow-up rates ranged from 84.2% to 91%. Clinical follow-up for PAD-related hospitalizations and major cardiovascular events is ongoing. Conclusions: PORTRAIT systematically collected serial PAD-specific health status data as a foundation for risk stratification, comparative effectiveness studies, and clinicians’ adherence to quality-based performance measures. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01419080.

[1]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[2]  S. Goldhaber,et al.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. , 2013, American heart journal.

[3]  Eric E. Smith,et al.  2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standar , 2012, Circulation.

[4]  J. Spertus,et al.  Medication Discussion Questions (MedDQ): Developing a Guide to Facilitate Patient-Clinician Communication About Heart Medications , 2011, The Journal of cardiovascular nursing.

[5]  Ryan J. Mays,et al.  Assessment of functional status and quality of life in claudication. , 2011, Journal of vascular surgery.

[6]  Elizabeth DeLong,et al.  ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Journal of the American College of Cardiology.

[7]  R. Bonow,et al.  ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Circulation.

[8]  A. O'Connor,et al.  Are you SURE?: Assessing patient decisional conflict with a 4-item screening test. , 2010, Canadian family physician Medecin de famille canadien.

[9]  D. Pittrow,et al.  Management of patients with peripheral arterial disease in primary care: a cross‐sectional study in Germany , 2010, International journal of clinical practice.

[10]  V. Aboyans,et al.  Characteristics and outcome of patients hospitalised for lower extremity peripheral artery disease in France: the COPART Registry. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  J. Denollet,et al.  Impact of peripheral arterial disease on health status: a comparison with chronic heart failure. , 2009, Journal of vascular surgery.

[12]  T. Strine,et al.  The PHQ-8 as a measure of current depression in the general population. , 2009, Journal of affective disorders.

[13]  M. Criqui,et al.  The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program , 2008, Vascular medicine.

[14]  H. Krumholz,et al.  Financial barriers to health care and outcomes after acute myocardial infarction. , 2007, JAMA.

[15]  M. Chiariello,et al.  Mortality in Peripheral Arterial Disease: A Comparison of Patients Managed by Vascular Specialists and General Practitioners , 2007, Journal of General Internal Medicine.

[16]  J. Spertus,et al.  Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization , 2007, Circulation.

[17]  J. Blacher,et al.  Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study. , 2006, Journal of vascular surgery.

[18]  C. Kalbaugh,et al.  One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. , 2006, Journal of vascular surgery.

[19]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[20]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[21]  Johan Denollet,et al.  DS14: Standard Assessment of Negative Affectivity, Social Inhibition, and Type D Personality , 2005, Psychosomatic medicine.

[22]  J. Dumville,et al.  The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.

[23]  J. Spertus,et al.  The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. , 2004, American heart journal.

[24]  Gail Ironson,et al.  A short social support measure for patients recovering from myocardial infarction: the ENRICHD Social Support Inventory. , 2003, Journal of cardiopulmonary rehabilitation.

[25]  M. Suarez‐Almazor,et al.  The prevalence of peripheral arterial disease in a racially diverse population. , 2003, Archives of internal medicine.

[26]  L. Holmberg,et al.  Areas of concern, quality of life and life satisfaction in patients with peripheral vascular disease. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[27]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[28]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[29]  L. Fried,et al.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. , 2000, Circulation.

[30]  R. Spitzer,et al.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.

[31]  P. Greenland,et al.  Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. , 1999, Archives of internal medicine.

[32]  D. Bloch,et al.  A simple method of sample size calculation for linear and logistic regression. , 1998, Statistics in medicine.

[33]  R. Deber,et al.  What role do patients wish to play in treatment decision making? , 1996, Archives of internal medicine.

[34]  F. Fowkes,et al.  The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. , 1992, Journal of clinical epidemiology.

[35]  F. Fowkes,et al.  The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. , 1988, International journal of epidemiology.

[36]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[37]  J. Cigarroa,et al.  Correction to: 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Circulation.

[38]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[39]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .